Literature DB >> 20016135

Growth hormone internalization in mitochondria decreases respiratory chain activity.

Dominique Ardail1, Aude Debon, Cécile Perret-Vivancos, Marie-Claire Biol-N'Garagba, Slavika Krantic, Peter E Lobie, Gérard Morel.   

Abstract

Growth hormone (GH) is a signaling molecule regulating cell proliferation, differentiation and metabolism via activation of specific cell surface receptors and subsequent triggering of signal transduction pathways. This is associated with GH/GH receptor internalization and accumulation of GH in several subcellular compartments, including mitochondria. To assess the functional relevance of such mitochondrial accumulation, we first confirmed the occurrence of mitochondrial GH uptake ex vivo as early as 10 min after (125)I-GH injection to the rats. We next showed that intact (125)I-GH accumulates in mitochondrial fractions in vitro in a specific, rapid and saturable manner with an apparent affinity (K(d)) of 1.44 nM. At the electron-microscopic level, immunoreactive GH density within mitochondria increased after in vitro hormone incubation, without any modification of the sub-mitochondrial distribution pattern. The presence of GH in the inter-membrane space and at the inner membrane seen by electron microscopy was confirmed by SDS-PAGE and autoradiography after mitochondrial fractioning thus suggesting the involvement of GH in the respiration control. To test this hypothesis further, we performed polarographic and spectrophotometric assays on isolated mitochondria. These assays pointed to a direct, selective and dose-dependent effect of GH on the inhibition of succinate dehydrogenase and cytochrome C oxidase activities. The latter inhibition was in contrast with indirect, GH receptor-initiated stimulation of cytochrome C oxidase activity observed in GH-treated whole BRL cells transfected to express this receptor. Altogether, these data show that GH is specifically imported in mitochondria, where it operates a direct metabolic effect, independently of cell surface receptors and signal transduction. Copyright 2009 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20016135     DOI: 10.1159/000268289

Source DB:  PubMed          Journal:  Neuroendocrinology        ISSN: 0028-3835            Impact factor:   4.914


  12 in total

Review 1.  The mitochondrial component of intracrine action.

Authors:  Richard N Re; Julia L Cook
Journal:  Am J Physiol Heart Circ Physiol       Date:  2010-07-09       Impact factor: 4.733

2.  Exogenous growth hormone attenuates cognitive deficits induced by intermittent hypoxia in rats.

Authors:  R C Li; S Z Guo; M Raccurt; E Moudilou; G Morel; K R Brittian; D Gozal
Journal:  Neuroscience       Date:  2011-08-23       Impact factor: 3.590

Review 3.  G protein-coupled receptor signalling in the cardiac nuclear membrane: evidence and possible roles in physiological and pathophysiological function.

Authors:  Artavazd Tadevosyan; George Vaniotis; Bruce G Allen; Terence E Hébert; Stanley Nattel
Journal:  J Physiol       Date:  2011-12-19       Impact factor: 5.182

Review 4.  Growth Hormone and Counterregulation in the Pathogenesis of Diabetes.

Authors:  Xuehong Dong; Lei Su; Mary-Elizabeth Patti
Journal:  Curr Diab Rep       Date:  2022-08-24       Impact factor: 5.430

5.  Hypoxia and cytoplasmic alkalinization upregulate growth hormone expression in lymphocytes.

Authors:  Douglas A Weigent
Journal:  Cell Immunol       Date:  2013-04-11       Impact factor: 4.868

6.  The Effect of Growth Hormone Administration on the Regulation of Mitochondrial Apoptosis in-Vivo.

Authors:  James Keane; Lotti Tajouri; Bon Gray
Journal:  Int J Mol Sci       Date:  2015-06-05       Impact factor: 5.923

7.  Growth Hormone Deteriorates the Functional Outcome in an Experimental Model of Huntington's Disease Induced by 3-Nitropionic Acid.

Authors:  Jung-Eun Park; Soon-Tae Lee; Woo-Seok Im; Manho Kim
Journal:  J Mov Disord       Date:  2013-10-30

Review 8.  Chronic limb-threatening ischemia could benefit from growth hormone therapy for wound healing and limb salvage.

Authors:  Diego Caicedo; Pablo Devesa; Víctor M Arce; Julia Requena; Jesús Devesa
Journal:  Ther Adv Cardiovasc Dis       Date:  2017-12-22

9.  Recombinant human growth hormone and insulin-like growth factor-1 do not affect mitochondrial derived highly reactive oxygen species production in peripheral blood mononuclear cells under conditions of substrate saturation in-vitro.

Authors:  James Keane; Lotti Tajouri; Bon Gray
Journal:  Nutr Metab (Lond)       Date:  2016-07-04       Impact factor: 4.169

Review 10.  Growth Hormone (GH) and Cardiovascular System.

Authors:  Diego Caicedo; Oscar Díaz; Pablo Devesa; Jesús Devesa
Journal:  Int J Mol Sci       Date:  2018-01-18       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.